Volume 24, Number 7—July 2018
Synopsis
Typhus Group Rickettsiosis, Germany, 2010–20171
Jessica Rauch, Philip Eisermann, Bernd Noack, Ute Mehlhoop, Birgit Muntau, Johannes Schäfer, and Dennis Tappe
Table 2
Serologic testing results for 28 patients with typhus group rickettsiosis, Germany, 2010–2017
| Category | Result, % patients | Days of illness during which serologic results were obtained, range (median) |
|---|---|---|
| Observed seroconversion | 18 (always with parallel IgM, IgA, and IgG detection)* | 10–41 (12)† |
| Parallel IgM and IgG/total Ig detection in first sample | 64 | 7–180 (10)‡ |
| Parallel IgM, IgA, and IgG detection in first sample | 46 | 7–39 (10) |
| Only 1 IgG or total Ig titer of >320 in any sample | 14 | 10–99 (14)§ |
*1 patient showed 1 typhus group rickettsiae–specific IgM in the first sample, followed by IgA and IgG seroconversion in the follow-up sample.
†1 patient returned 41 d after the initial visit and showed seroconversion.
‡For 1 patient, serum was collected 180 d after a disease compatible with typhus group rickettsiosis had occurred.
§For 1 patient, serum was collected 99 d after a disease compatible with typhus group rickettsiosis had occurred.
1Part of this study was orally presented at the annual meeting of the German Society for Hygiene and Microbiology, February 19–21, 2018, Bochum, Germany.
Page created: June 18, 2018
Page updated: June 18, 2018
Page reviewed: June 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.